MERCURY LABORATORIES
Back to Cashflow Statement
|
MERCURY LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-1.01 Cr | ₹-1.23 Cr | ₹-1.24 Cr | ₹-3.33 Cr | ₹-2.54 Cr |
What is the latest Cash Flow from Financing Activities ratio of MERCURY LABORATORIES ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2023 | ₹-1.01 Cr |
Mar2022 | ₹-1.23 Cr |
Mar2021 | ₹-1.24 Cr |
Mar2020 | ₹-3.33 Cr |
Mar2019 | ₹-2.54 Cr |
How is Cash Flow from Financing Activities of MERCURY LABORATORIES Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2023 | ₹-1.01 Cr | Negative | |
Mar2022 | ₹-1.23 Cr | Negative | |
Mar2021 | ₹-1.24 Cr | Negative | |
Mar2020 | ₹-3.33 Cr | Negative | |
Mar2019 | ₹-2.54 Cr | - |
Compare Cash Flow from Financing Activities of peers of MERCURY LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MERCURY LABORATORIES | ₹124.1 Cr | -5.4% | 6.4% | 25.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹447,596.0 Cr | -0.4% | 4.7% | 60.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹144,695.0 Cr | -1.1% | 11% | 43.2% | Stock Analytics | |
CIPLA | ₹132,401.0 Cr | -1.3% | 2.8% | 33.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,341.0 Cr | -2.3% | -7.8% | 14.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹106,198.0 Cr | -5.7% | -12.6% | 68.7% | Stock Analytics |
MERCURY LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MERCURY LABORATORIES | -5.4% |
6.4% |
25.9% |
SENSEX | 2% |
4.5% |
25.2% |
You may also like the below Video Courses